Correction: Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo

Correction: Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729295/?tool=EBI

Similar Items

Correction: Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo.
by: Julia Reetz, et al.
Published: (2013-01-01)

Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo.
by: Julia Reetz, et al.
Published: (2013-01-01)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
by: Wenhao Li, et al.
Published: (2020-04-01)

Hepatic Stellate Cells and Hepatocarcinogenesis
by: Anna E. Barry, et al.
Published: (2020-08-01)

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling.
by: Ikuo Nakamura, et al.
Published: (2015-01-01)

Human adenoviral type 54 keratoconjunctivitis accompanied by stellate keratitis and keratic precipitates: two cases
by: Kazuki Matsuura, et al.
Published: (2019-01-01)

Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
by: Marta García, et al.
Published: (2022-12-01)

Peptide-Based siRNA Nanocomplexes Targeting Hepatic Stellate Cells
by: Chien-Yu Lin, et al.
Published: (2023-02-01)

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
by: Xiaochun Yin, et al.
Published: (2022-11-01)

Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers
by: Menna Azzam, et al.
Published: (2020-06-01)

Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study
by: Naglaa M. El-Lakkany, et al.
Published: (2019-01-01)

Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments.
by: Sumiyo Watanabe, et al.
Published: (2017-01-01)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
by: Kelly, C, et al.
Published: (2012)

miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
by: Kang Hui, et al.
Published: (2023-12-01)

Author Correction: Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx
by: Jin Gong, et al.
Published: (2021-03-01)

Proteomic Changes of Activated Hepatic Stellate Cells
by: Maximilian Schinagl, et al.
Published: (2021-11-01)

On the presence of hepatic stellate cells in portal spaces
by: Yánnick de Oliveira Fonseca, et al.
Published: (2005-05-01)

Irisin Regulates the Functions of Hepatic Stellate Cells
by: Hanh Nguyen Dong, et al.
Published: (2020-09-01)

Hepatic Stellate Cell-Immune Interactions in NASH
by: James K. Carter, et al.
Published: (2022-06-01)

Hepatic Stellate Cells in the Context of Liver Fibrosis
by: Muhammad Ashfaq khan, et al.
Published: (2013-09-01)

Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
by: Hans-Theo eSchon, et al.
Published: (2016-02-01)

Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic review
by: Dengcheng Hui, et al.
Published: (2023-03-01)

Readministration of adenoviral gene delivery to dopamine neurons.
by: Gonzalez, S, et al.
Published: (2007)

Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients
by: Juliane Kager, et al.
Published: (2022-07-01)

Author Correction: MircoRNA-145 promotes activation of hepatic stellate cells via targeting krüppel-like factor 4
by: Ruoting Men, et al.
Published: (2023-06-01)

Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma
by: Ya-Nan Ma, et al.
Published: (2021-11-01)

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
by: Alexandra Zisser, et al.
Published: (2021-03-01)

Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation
by: Mustapha Najimi, et al.
Published: (2017-06-01)

Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts
by: Kunz Dagmar, et al.
Published: (2000-12-01)

Correction: Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica.
by: Xing He, et al.
Published: (2020-01-01)

Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis
by: Siti Aishah Sulaiman, et al.
Published: (2021-11-01)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
by: Yuan-Quan Zhao, et al.
Published: (2023-04-01)

Insights into the impact of hepatitis B virus on hepatic stellate cell activation
by: Hongjuan You, et al.
Published: (2023-04-01)

Adenoviral Producer Cells
by: Imre Kovesdi, et al.
Published: (2010-08-01)

Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells
by: Koichi Fujisawa, et al.
Published: (2020-05-01)

Hepatic Stellate Cell Regulation of Liver Regeneration and Repair
by: Laura J. Kitto, et al.
Published: (2021-03-01)

Epigenetic Changes during Hepatic Stellate Cell Activation.
by: Silke Götze, et al.
Published: (2015-01-01)

Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
by: Wei Hou, et al.
Published: (2018-11-01)

Hepatic stellate cells and parasite-induced liver fibrosis
by: Li Yuesheng S, et al.
Published: (2010-07-01)

Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells
by: J.C. Shu, et al.
Published: (2009-12-01)